Frequently Asked Questions about the Molecular Basis of Cancer, Therapeutics and Targets

Question 1

What does the Molecular Basis of Cancer course cover?

Accepted Answer

The course covers oncogenes, tumor suppressor genes, DNA damage, cell-cycle dysregulation, apoptosis, cancer metabolism, tumor microenvironment, metastasis, signaling pathways, biomarkers, targeted therapies, immunotherapies, drug resistance, and precision oncology.

Question 2

Who should take this molecular cancer biology course?

Accepted Answer

The course is suitable for biotechnology students, molecular biology learners, cancer researchers, biomedical scientists, pharmacology students, medical professionals, pharmaceutical researchers, doctoral scholars, academicians, clinical researchers, and precision-oncology professionals.

Question 3

What is the molecular basis of cancer?

Accepted Answer

The molecular basis of cancer refers to genetic, epigenetic, biochemical, and cellular changes that disrupt normal growth control and enable uncontrolled proliferation, survival, invasion, and metastasis.

Question 4

What are oncogenes?

Accepted Answer

Oncogenes are activated or overexpressed genes that promote cell growth, survival, or proliferation and can contribute to cancer development when abnormally regulated.

Question 5

What are tumor suppressor genes?

Accepted Answer

Tumor suppressor genes normally restrict cell growth, repair DNA damage, maintain genomic stability, or trigger cell death. Their loss or inactivation can support tumor formation.

Question 6

How does cell-cycle dysregulation contribute to cancer?

Accepted Answer

Cell-cycle dysregulation allows damaged or abnormal cells to continue dividing by disrupting checkpoints, regulatory proteins, and growth-control mechanisms.

Question 7

What role does DNA damage play in cancer?

Accepted Answer

Unrepaired DNA damage can create mutations, chromosome abnormalities, and genomic instability that activate oncogenes or disable tumor suppressor pathways.

Question 8

What is apoptosis and why is it important in cancer?

Accepted Answer

Apoptosis is programmed cell death. Cancer cells may evade apoptosis, allowing damaged or genetically abnormal cells to survive and accumulate.

Question 9

What is cancer metabolism?

Accepted Answer

Cancer metabolism refers to altered nutrient use and energy production that help tumor cells grow, survive stress, produce biomass, and adapt to changing environments.

Question 10

What is the tumor microenvironment?

Accepted Answer

The tumor microenvironment includes cancer cells, immune cells, blood vessels, fibroblasts, extracellular matrix, signaling molecules, and surrounding tissues that influence tumor behavior.

Question 11

How do cancer cells metastasize?

Accepted Answer

Metastasis involves local invasion, entry into blood or lymphatic vessels, survival during circulation, exit into distant tissues, and growth at a new site.

Question 12

What are cancer signaling pathways?

Accepted Answer

Cancer signaling pathways are molecular communication networks that regulate cell growth, survival, metabolism, movement, immune interactions, and responses to the environment.

Question 13

What is a therapeutic target in cancer?

Accepted Answer

A therapeutic target is a molecule, pathway, receptor, enzyme, mutation, or cellular process that can be altered by treatment to inhibit cancer growth or survival.

Question 14

What are targeted cancer therapies?

Accepted Answer

Targeted therapies act on specific molecular abnormalities or dependencies in cancer cells, such as altered receptors, kinases, signaling proteins, or DNA-repair mechanisms.

Question 15

What are cancer biomarkers?

Accepted Answer

Cancer biomarkers are measurable biological features associated with cancer detection, classification, prognosis, treatment selection, response, or disease monitoring.

Question 16

What is a companion diagnostic?

Accepted Answer

A companion diagnostic is a test used to identify patients who may benefit from or be at increased risk from a particular targeted treatment.

Question 17

How does immunotherapy treat cancer?

Accepted Answer

Immunotherapy enhances, redirects, or restores immune responses against cancer using approaches such as immune-checkpoint inhibitors, engineered immune cells, antibodies, vaccines, or immune-modulating agents.

Question 18

Why does cancer treatment resistance occur?

Accepted Answer

Resistance can arise through new mutations, pathway reactivation, drug-efflux mechanisms, altered targets, tumor heterogeneity, microenvironmental protection, or selection of resistant cell populations.

Question 19

What is precision oncology?

Accepted Answer

Precision oncology uses molecular, genomic, pathological, and clinical information to guide cancer prevention, diagnosis, treatment selection, and monitoring for individual patients.

Question 20

Can molecular biomarkers guarantee treatment success?

Accepted Answer

No. Biomarkers can support treatment selection and risk assessment, but clinical outcomes also depend on tumor heterogeneity, disease stage, patient health, resistance, treatment access, and other biological factors.

Question 21

What emerging strategies are being explored in cancer therapy?

Accepted Answer

Emerging strategies include personalized vaccines, cellular therapies, synthetic-lethal targeting, antibody-drug conjugates, RNA therapeutics, epigenetic treatments, nanomedicine, and biomarker-guided combination therapies.

Question 22

What skills can learners gain from this course?

Accepted Answer

Learners can develop an understanding of cancer genetics, signaling pathways, tumor biology, biomarkers, therapeutic targets, targeted therapy, immunotherapy, resistance mechanisms, precision oncology, and emerging molecular treatment strategies.

Brand	NSTC
Format	Online (e-LMS)
Duration	3 Months
Level	Advanced
Hands-On	Yes – Practical projects with industrial datasets

Molecular Basis of Cancer: Therapeutics and Targets

About the Molecular Basis Of Cancer Course

Program Highlights

Course Curriculum

Module 1: Introduction to Cancer Biology

Module 2: Oncogenes and Tumor Suppressors

Module 3: Signal Transduction in Cancer

Module 4: Tumor Microenvironment & Cancer Stem Cells

Module 5: Molecular Diagnostics and Biomarkers

Module 6: Genomics and Precision Profiling

Module 7: Targeted Cancer Therapeutics

Tools, Techniques, or Platforms Covered

Real-World Applications

Who Should Attend & Prerequisites